Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds.
Nosanchuk
Joshua D
JD
Department of Medicine, Division of Infectious Diseases, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA. nosanchu@aecom.yu.edu
Casadevall
Arturo
A
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000935:Antifungal Agents / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects* / Q000378:metabolism / Q000472:pathogenicity*; D002473:Cell Wall / Q000187:drug effects; D024881:Drug Resistance, Bacterial / Q000187:drug effects; D025141:Drug Resistance, Fungal / Q000187:drug effects; D005658:Fungi / Q000187:drug effects* / Q000378:metabolism / Q000472:pathogenicity*; D006801:Humans; D008543:Melanins / Q000378:metabolism / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D016062:Porosity / Q000187:drug effects
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D008543:Melanins